Barclays’s Dianthus Therapeutics DNTH Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $1.21M | Buy |
64,821
+33,680
| +108% | +$628K | ﹤0.01% | 2541 |
|
2025
Q1 | $565K | Sell |
31,141
-11,625
| -27% | -$211K | ﹤0.01% | 2769 |
|
2024
Q4 | $933K | Buy |
42,766
+1,082
| +3% | +$23.6K | ﹤0.01% | 2672 |
|
2024
Q3 | $1.14M | Buy |
41,684
+33,185
| +390% | +$908K | ﹤0.01% | 2545 |
|
2024
Q2 | $220K | Sell |
8,499
-5,904
| -41% | -$153K | ﹤0.01% | 3000 |
|
2024
Q1 | $432K | Buy |
14,403
+14,400
| +480,000% | +$432K | ﹤0.01% | 2919 |
|
2023
Q4 | $0 | Buy |
+3
| New | – | ﹤0.01% | 4226 |
|
2023
Q3 | – | Sell |
-3
| Closed | – | – | 4277 |
|
2023
Q2 | $0 | Hold |
3
| – | – | ﹤0.01% | 4274 |
|
2023
Q1 | $0 | Sell |
3
-330
| -99% | – | ﹤0.01% | 4322 |
|
2022
Q4 | $2K | Sell |
333
-120
| -26% | -$721 | ﹤0.01% | 4284 |
|
2022
Q3 | $10K | Sell |
453
-87
| -16% | -$1.92K | ﹤0.01% | 4167 |
|
2022
Q2 | $10K | Sell |
540
-287
| -35% | -$5.32K | ﹤0.01% | 4310 |
|
2022
Q1 | $38K | Sell |
827
-1,966
| -70% | -$90.3K | ﹤0.01% | 4106 |
|
2021
Q4 | $198K | Buy |
2,793
+1,505
| +117% | +$107K | ﹤0.01% | 2832 |
|
2021
Q3 | $151K | Sell |
1,288
-354
| -22% | -$41.5K | ﹤0.01% | 3090 |
|
2021
Q2 | $257K | Sell |
1,642
-552
| -25% | -$86.4K | ﹤0.01% | 2789 |
|
2021
Q1 | $415K | Sell |
2,194
-224
| -9% | -$42.4K | ﹤0.01% | 2752 |
|
2020
Q4 | $304K | Buy |
2,418
+267
| +12% | +$33.6K | ﹤0.01% | 2535 |
|
2020
Q3 | $233K | Buy |
2,151
+788
| +58% | +$85.4K | ﹤0.01% | 2659 |
|
2020
Q2 | $164K | Buy |
1,363
+823
| +152% | +$99K | ﹤0.01% | 2904 |
|
2020
Q1 | $55K | Sell |
540
-665
| -55% | -$67.7K | ﹤0.01% | 3058 |
|
2019
Q4 | $292K | Buy |
1,205
+572
| +90% | +$139K | ﹤0.01% | 2989 |
|
2019
Q3 | $104K | Sell |
633
-392
| -38% | -$64.4K | ﹤0.01% | 3382 |
|
2019
Q2 | $242K | Buy |
1,025
+507
| +98% | +$120K | ﹤0.01% | 3100 |
|
2019
Q1 | $137K | Buy |
518
+352
| +212% | +$93.1K | ﹤0.01% | 3191 |
|
2018
Q4 | $15K | Buy |
166
+71
| +75% | +$6.42K | ﹤0.01% | 3454 |
|
2018
Q3 | $18K | Buy |
+95
| New | +$18K | ﹤0.01% | 3940 |
|